Dr. Greg Hobelmann, Co-CEO/President of Ashley Addiction Treatment alongside Alex Denstman, brings a wealth of experience to his role. Formerly serving as senior vice president and chief clinical/medical officer, Greg now oversees our entire continuum of care including Medical, Clinical, and Spiritual Care, as well as Family Services, Quality Improvement, and Health Information Management. Holding a Master of Public Health from Johns Hopkins Bloomberg School of Public Health, Greg’s expertise spans psychiatry, anesthesiology, and pain medicine. With a background in interventional pain management, he focuses on substance use disorders and chronic pain, dedicated to providing innovative holistic care to patients and families at Ashley. Greg currently serves as Secretary on the Executive Committee for the National Association of Addiction Treatment Providers and is Co-Chair of the Public Policy Committee for the Maryland/DC Society of Addiction Medicine.
